NYLIM Candriam U.S. Mid Cap Equity ETF
IQSM
3 hedge funds and large institutions have $202M invested in NYLIM Candriam U.S. Mid Cap Equity ETF in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.16% less ownership
Funds ownership: 99.6% → 99.44% (-0.16%)
4% less capital invested
Capital invested by funds: $210M → $202M (-$7.44M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NYLIM
New York Life Investment Management
New York
|
+$4.88M |
| 2 |
SI
Seeds Investor
New York
|
+$161K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$107K |
Top Sellers
IQSM Hedge Fund Activity: Q1 2025 in Review
3 of the 7,473 institutional investors tracked by Wall St. Rank reported a position in NYLIM Candriam U.S. Mid Cap Equity ETF (IQSM) for Q1 2025, worth a combined $202M — down 3.6% from $210M a quarter earlier.
Fund positioning in IQSM was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was New York Life Investment Management, adding an estimated $4.88M.
- 3 institutional investors held NYLIM Candriam U.S. Mid Cap Equity ETF (IQSM) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $202M of NYLIM Candriam U.S. Mid Cap Equity ETF stock for Q1 2025, down 3.6% quarter-over-quarter.
- 0 funds opened new NYLIM Candriam U.S. Mid Cap Equity ETF positions in Q1 2025 and 0 closed out.
- The largest NYLIM Candriam U.S. Mid Cap Equity ETF buyer in Q1 2025 was New York Life Investment Management, an estimated $4.88M added.
Based on aggregated 13F filings for Q1 2025.